Search research articles
Contact Us
Filters
Showing results (491-500 of 740) with videos related to
Page
of 74
Sort By:
Circulation Research
|
April 27, 2016
Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration
Jeffrey S Monette, Patrick M Hutchins, Graziella E Ronsein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors
Matthew J O'Shaughnessy, Katie S Murray, Stephen P La Rosa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 29, 2015
iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
Xue Li, Thorsten Maretzky, Gisela Weskamp, et al.
Journal of Cell Science
|
January 8, 2010
Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA
Levon G Abrahamyan, Laurent Chatel-Chaix, Lara Ajamian, et al.
Blood
|
October 7, 2020
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis
Xinfang Yu, Wei Li, Qipan Deng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2002
In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat
Tsutomu Kotegawa, Bart E Laurijssens, Lisa L Von Moltke, et al.
Cancer Research
|
January 25, 2018
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models
Sai Kiran Sharma, Andrew Chow, Sebastien Monette, et al.
European Journal of Immunology
|
August 9, 2014
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation
Nathalie E Blachère, Dana E Orange, Bianca D Santomasso, et al.
Blood
|
August 13, 2009
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Francesco Parlati, Susan J Lee, Monette Aujay, et al.
Blood
|
January 30, 2010
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Monette Aujay, et al.
Page
of 74
Search research articles
Search
Showing results (491-500 of 740) with videos related to
Sort By:
Page
of 74
Circulation Research
|
April 27, 2016
Patients With Coronary Endothelial Dysfunction Have Impaired Cholesterol Efflux Capacity and Reduced HDL Particle Concentration
Jeffrey S Monette, Patrick M Hutchins, Graziella E Ronsein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
Systemic Antitumor Immunity by PD-1/PD-L1 Inhibition Is Potentiated by Vascular-Targeted Photodynamic Therapy of Primary Tumors
Matthew J O'Shaughnessy, Katie S Murray, Stephen P La Rosa, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 29, 2015
iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
Xue Li, Thorsten Maretzky, Gisela Weskamp, et al.
Journal of Cell Science
|
January 8, 2010
Novel Staufen1 ribonucleoproteins prevent formation of stress granules but favour encapsidation of HIV-1 genomic RNA
Levon G Abrahamyan, Laurent Chatel-Chaix, Lara Ajamian, et al.
Blood
|
October 7, 2020
MYD88 L265P elicits mutation-specific ubiquitination to drive NF-κB activation and lymphomagenesis
Xinfang Yu, Wei Li, Qipan Deng, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 17, 2002
In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat
Tsutomu Kotegawa, Bart E Laurijssens, Lisa L Von Moltke, et al.
Cancer Research
|
January 25, 2018
Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models
Sai Kiran Sharma, Andrew Chow, Sebastien Monette, et al.
European Journal of Immunology
|
August 9, 2014
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation
Nathalie E Blachère, Dana E Orange, Bianca D Santomasso, et al.
Blood
|
August 13, 2009
Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome
Francesco Parlati, Susan J Lee, Monette Aujay, et al.
Blood
|
January 30, 2010
Selective inhibition of chymotrypsin-like activity of the immunoproteasome and constitutive proteasome in Waldenstrom macroglobulinemia
Aldo M Roccaro, Antonio Sacco, Monette Aujay, et al.
Page
of 74